Skip to content

SAS-J Compared to OAGB and LSG as a Treatment for Morbid Obesity

Single Anastomosis Sleeve Jejunal Bypass Compared to One Anastomosis Gastric Bypass and Sleeve Gastrectomy as a Treatment for Morbid Obesity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03821688
Enrollment
210
Registered
2019-01-30
Start date
2019-03-15
Completion date
2020-08-10
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Brief summary

150 morbidly obese patients divided into to equal groups, group A underwent single anastomosis sleeve jejunal bypass and group B underwent mini gastric bypass, group C underwent sleeve gastrectomy. All patients were followed for at least one year. all cases were evaluated as regard BMI, complications, nutritional status and obesity-related comorbidities.

Detailed description

150 morbidly obese patients divided into to equal groups, group A underwent single anastomosis sleeve jejunal bypass and group B underwent mini gastric bypass, group C underwent sleeve gastrectomy. All patients were followed for at least one year. all cases were evaluated as regard BMI, complications, nutritional status and obesity-related comorbidities. the minimal follow up period is one year

Interventions

PROCEDURESAS-JB

single anastomosis sleeve jejunal bypass

PROCEDUREOAGB

one anastomosis gastric bypass

PROCEDURELSG

laproscopic sleeve gastrectomy

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* obese patients with BMI more than 40 with or without co-morbidity or more than 35 with co-morbidity * patients fit for laparoscopic surgery * give approval to share in the study

Exclusion criteria

* patients refused to share in the study * patients unfit for surgery * patients aged less than 18 and older than 60 * patient with previous upper abdominal surgery either for obesity or other diseases * revisional bariatric procedures

Design outcomes

Primary

MeasureTime frameDescription
percentage of excess weight loss12 monthspercentage of excess weight loss in kilogram

Secondary

MeasureTime frameDescription
the incidence of nutritional deficiency2 yearsthe incidence of nutritional deficiency like anemia, hypocalcamia, hypoproteinemia.
the rate of improved co morbidity2 yearsthe effect of the operation on co morbidity like diabetes and hypertension
the incidence of early operative complicationsone monthearly operative complications like leak, bleeding

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026